Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Beardsell Limited's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
Only peers present in the company profile payload are displayed.
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Beardsell Ltd is Rated Sell MarketsMojo
Beardsell Closes Trading Window Ahead of June-Quarter Results TipRanks
Enterprise value to EBITDA forward of Beardsell Limited – NSE:BEARDSELL TradingView
Price to book forward of Beardsell Limited – NSE:BEARDSELL TradingView
Compare with Equitymaster
LiveLawBiz IPR Weekly Digest: June 01 - June 07, 2026 LiveLawBiz
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Not available
Beardsell Limited has the symbol BEARDSELL and ISIN - INE520H01022.
Beardsell Limited is currently trading at INR 24.48.
Beardsell Limited has a year high of INR 38.60 and a year low of INR 20.02.
Beardsell Limited has a market capitalization of NA.
Beardsell Limited has a P/E ratio of NA.
Beardsell Limited has a dividend yield of NA.
Beardsell Limited has revenue of NA, net income of NA, and EPS of NA.
Beardsell Limited has a book value of NA.
Beardsell Limited has a debt-to-equity ratio of NA.
Beardsell Limited has a price-to-book ratio of NA and a price-to-sales ratio of NA.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.